NCT02265653View on ClinicalTrials.gov

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

December 31, 1999

Conditions
Healthy
Interventions
DRUG

BIIL 284 BS tablet C

DRUG

BIIL 284 BS tablet D

DRUG

BIIL 284 BS WIF tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY